Similar Stories to In New Alzheimer’s Criteria, Some See Progress While Others Fear Profit-driven ‘diagnostic Creep’ - Cnn on Bing News

In new Alzheimer’s criteria, some see progress while others fear profit-driven ‘diagnostic creep’ CNNView Full Coverage on Google News

BING NEWS:
  • New Alzheimer’s drug gets FDA approval
    Click in for more news from The Hill{beacon} Health Care Health Care  The Big Story New Alzheimer’s drug gets FDA approval The Food and Drug Administration (FDA) on Tuesday ...
    07/2/2024 - 11:45 am | View Link
  • FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
    The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
    07/2/2024 - 8:20 am | View Link
  • In new Alzheimer’s criteria, some see progress while others fear profit-driven ‘diagnostic creep’
    The Last Alzheimer’s Patient” airs at 8 p.m. ET Sunday, July 7, on CNN. With another pricey Alzheimer’s disease treatment expected to receive an approval decision soon, the nonprofit Alzheimer’s ...
    07/1/2024 - 3:56 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Politics News